Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF- B activation

Chun, Kyung Soo; Keum, Young‐Soo; Han, Seong‐Su; Song, Yong Sang; Kim, Su Hyeong; Surh, Young Joon

doi:10.1093/carcin/bgg107

Cited by 283 publications

(236 citation statements)

References 46 publications

Supporting

Mentioning

218

Contrasting

Unclassified

Order By: Relevance

“…Curcumin was found to suppress COX-2 expression by inhibiting extracellular signal-regulated kinase (ERK) activity and NF-κB in phorbol ester-induced mouse skin tumorigenesis [26]. Curcumin has also been shown to induce growth arrest and apoptosis in various cancer cell lines [67,80,154,169].…”

Section: Pre-clinical and Clinical Trials Of Nf-κb Inhibitorsmentioning

confidence: 99%

NF‐κB as a potential molecular target for cancer therapy

et al. 2007

View full text Add to dashboard Cite

Abstract. Nuclear factor κB (NF-κB), a transcription factor, plays an important role in carcinogenesis as well as in the regulation of immune and inflammatory responses. NF-κB induces the expression of diverse target genes that promote cell proliferation, regulate apoptosis, facilitate angiogenesis and stimulate invasion and metastasis. Furthermore, many cancer cells show aberrant or constitutive NF-κB activation which mediates resistance to chemo-and radio-therapy. Therefore, the inhibition of NF-κB activation and its signaling pathway offers a potential cancer therapy strategy. In addition, recent studies have shown that NF-κB can also play a tumor suppressor role in certain settings. In this review, we focus on the role of NF-κB in carcinogenesis and the therapeutic potential of targeting NF-κB in cancer therapy.Keywords: NF-κB, NF-κB inhibitor, carcinogenesis, cancer therapy Structure, function and regulation of NF-κBNuclear factor-κB (NF-κB) was first identified in 1986 as a transcription factor that binds to a 10 bp DNA element in kappa immunoglobulin light-chain enhancer in B cells [128]. The mammalian NF-κB family consists of 5 members: NF-κB1 (p50/p105), NF-κB2 (p52/p100), c-Rel, RelA (p65) and RelB (Fig. 1). RelA, c-Rel and RelB are synthesized in their mature forms and contain a transactivation domain that interacts with the transcriptional apparatus. On the other hand, NF-κB1 (p50/p105) and NF-κB2 (p52/p100) are synthesized in precursor forms (p100 and p105) which contain C-terminal ankyrin repeats that are proteolysed by the proteasome resulting in the production of mature proteins (p50 and p52). Both p50 and p52 contain a DNA binding domain but lack a transactivation domain. NF-κB proteins exist in unstimulated cells as homo-or heterodimers bound to IκB proteins. Whereas RelB forms only heterodimers, all the other proteins can form both homo-and heterodimers. NF-κB proteins are characterized by the presence of a highly conserved 300 amino acid Rel homology domain that is located toward the N terminus of the protein, and which is responsible for DNA binding, dimerization, and interaction with specific inhibitory factors known as IκB proteins [7,36].

show abstract

Section: Pre-clinical and Clinical Trials Of Nf-κb Inhibitorsmentioning

confidence: 99%

NF‐κB as a potential molecular target for cancer therapy

et al. 2007

View full text Add to dashboard Cite

show abstract

“…7,21 Equal amounts of protein extracts in RIPA lysis buffer [150 mM NaCl, 0.5% Triton X-100, 50 mM Tris-HCl (pH 7.4), 25 mM NaF, 20 mM EGTA, 1 mM DTT, 1 mM Na 3 VO 4 , and a protease-inhibitor-cocktail tablet] were subjected to 12% SDS-PAGE and electrophoretically transferred to nitrocellulose membrane. Protein bands were detected using an enhanced chemiluminescence detection kit.…”

Section: Immunoblot Analysismentioning

confidence: 99%

Section: Electrophoretic Mobility Shift Assaymentioning

confidence: 99%

“…21 An electrophoretic mobility shift assay (EMSA) was performed using a DNA-protein-binding detection kit (GIBCO BRL) for NFjB binding according to the Manufacturer's protocol as described previously. 21 Briefly, the NF-jB oligonucleotide probe (5 0 -AGT TGA GGG GAC TTT CCC AGG C-3 0 ) was labeled with [a-32 P]ATP by T4 polynucleotide kinase and purified on a Nick column. The binding reaction was performed in 25 ll of the mixture containing 5 ll of incubation buffer [10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 4% (v/v) glycerol and 0.1 mg/ml sonicated salmon sperm DNA], 10 lg of nuclear extracts and the labeled probe at 100,000 cpm.…”

Section: Electrophoretic Mobility Shift Assaymentioning

confidence: 99%

See 1 more Smart Citation

H‐Ras selectively up‐regulates MMP‐9 and COX‐2 through activation of ERK1/2 and NF‐κB: An implication for invasive phenotype in rat liver epithelial cells

Lee

Kim

Kang

et al. 2006

Intl Journal of Cancer

View full text Add to dashboard Cite

One of the most frequent events in carcinogenesis is uncontrolled activation of Ras signaling pathway. A previous study demonstrated that the introduction of H-Ras into the normal WB-F344 rat liver epithelial (WB) cell line and adult male F344 rats resulted in tumorigenicity. The present study investigated whether H-Ras induced the invasive and migrative phenotypes in WB cells, and subsequently aimed at characterizing the underlying mechanisms. H-Ras induced the invasive and migrative phenotypes of WB cells with a selective up-regulation of matrix metalloproteinase (MMP)-9, but not MMP-2. Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E 2 (PGE 2 ) were also induced by H-Ras. Treatment of H-Ras WB cells with GM6001 and NS398, the inhibitors of MMPs and COX-2, respectively, significantly inhibited the H-Ras-induced invasive and migrative phenotypes. DNA binding activity of nuclear factor (NF)-jB, but not that of activator protein (AP)-1, was increased by H-Ras. Caffeic acid phenethyl ester and Bay 11-7082, specific inhibitors of NF-jB and IKK, respectively, significantly inhibited the expression of MMP-9 and COX-2, invasion and migration of H-Ras WB cells, revealing NF-jB as a transcriptional factor responsible for HRas-induced malignant phenotypic conversion of WB cells. Activation of ERKs pathway was critical for H-Ras-induced invasive and migrative phenotypes, up-regulation of MMP-9 and COX-2 as well as enhanced DNA binding activity of NF-jB in WB cells. Taken together, these results demonstrate that H-Ras up-regulates MMP-9 and COX-2 through activation of ERKs and IKK-IjBa-NF-jB signal pathway which may contribute to the malignant progression of WB rat liver epithelial cells. ' 2006 Wiley-Liss, Inc.

show abstract

“…Recently, it has been reported that curcumin-treated cells show the decreased expressions of COX-2 in various cell lines by inhibition of MAPKs signaling pathways (Chun et al, 2003;Hong et al, 2004;Kang et al, 2004). Currently, it is unknown whether curcumin modulates the expression of COX-2 in UVB-irradiated HaCaT cells.…”

Section: Introductionmentioning

confidence: 99%